THAILAND

Salus Bioceutical Thailand establishes first state-of-the-art, high-capacity cannabis/hemp manufacturing and extraction laboratory in Asia in response to surging demand for CBD and THC products

Published on 27/12/2021

» Bangkok, Thailand, 22 December 2021 – Salus Bioceutical (Thailand) Co. Ltd. (SBT), in partnership with Salus International Management Ltd. (SIM), a partially-owned subsidiary of MPX International Corporation (MPXI), a multinational diversified cannabis company, is opening a 600-million-baht cannabis/hemp production plant (‘the Facility’) in Doi Saket district of Chiang Mai province in Thailand. The Facility will initially produce CBD products to cater to growing international and local demand, whereby THC products and medicine will be developed subject to government approval under applicable laws.